Latest Articles
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada
Published: July 2, 2025, 12:08 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener
Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener
Organon abandons endometriosis pain drug development after trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com
Organon halts development of endometriosis pain drug after trial failure Investing.com
Published: July 2, 2025, 11:42 a.m.
Aspira Loses $10M ARPA-H Contract but Vows to Continue Revolutionary Endometriosis Test Development - Stock Titan
Aspira Loses $10M ARPA-H Contract but Vows to Continue Revolutionary Endometriosis Test Development Stock Titan
Published: June 11, 2025, 12:30 p.m.
Development of a two-layer 3D equine endometrial tissue model using genipin-crosslinked collagen scaffolds and 3D printing - Nature
Development of a two-layer 3D equine endometrial tissue model using genipin-crosslinked collagen scaffolds and 3D printing Nature
Published: June 5, 2025, 10:08 a.m.
Sentosa Development Corporation And Mount Faber Leisure Group Celebrate - Business Post Nigeria
Sentosa Development Corporation And Mount Faber Leisure Group Celebrate Business Post Nigeria
Published: June 5, 2025, 2:29 a.m.
Empowering A Nation: The Critical Role Of Women’s Health In Nigeria’s Development - Leadership Newspapers
Empowering A Nation: The Critical Role Of Women’s Health In Nigeria’s Development Leadership Newspapers
Published: May 18, 2025, 6:14 a.m.
Health and care sector latest developments - NHS Confederation
Health and care sector latest developments NHS Confederation
Published: May 1, 2025, 5:48 p.m.
Gesynta Pharma AB Appoints Eva Johnsson as new Chief Medical Officer (CMO) / VP Clinical Development - beQuoted
Gesynta Pharma AB Appoints Eva Johnsson as new Chief Medical Officer (CMO) / VP Clinical Development beQuoted
Published: April 9, 2025, 12:15 p.m.
Link copied to clipboard!